Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference
Rhea-AI Summary
Chemed (NYSE:CHE) will present virtually at the Oppenheimer 36th Annual Healthcare Conference on March 19, 2026 at ~9:20 a.m. ET. The live webcast and presentation materials will be available on Chemed's investor site, with a replay posted within 24 hours and accessible for 90 days.
Chemed operates two subsidiaries: VITAS Healthcare (hospice) and Roto-Rooter (plumbing and drain services), and cautioned that forward-looking statements are subject to risks and may change.
Positive
- None.
Negative
- None.
News Market Reaction – CHE
In the Mar 12 session, CHE declined 0.79%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 25 | Q4 2025 earnings | Negative | -0.4% | Flat revenue with declining GAAP and adjusted EPS versus prior year. |
| Feb 13 | Buyback & dividend | Positive | +2.0% | Additional $300M repurchase authorization and continued $0.60 quarterly dividend. |
| Jan 02 | Earnings date set | Neutral | -0.9% | Announced Q4 2025 release date and related conference call logistics. |
| Dec 04 | Investor conference | Neutral | -1.5% | Virtual home care conference presentation with webcast and 90-day replay access. |
| Nov 25 | Brand/hospice campaign | Positive | +1.0% | VITAS video highlighting benefits of hospice-at-home during National Care at Home Month. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent Chemed headlines, whether earnings, capital return, or conference appearances, have typically produced modest price moves that align with the news tone, with neutral conference or scheduling updates sometimes seeing slight pullbacks.
Over the last several months, Chemed has reported mixed Q4 2025 results with flat revenue of $639.3M and lower EPS, while maintaining a strong balance sheet and issuing 2026 adjusted EPS guidance of $23.25–$24.25. The Board added $300M to its repurchase authorization and declared a $0.60 quarterly dividend, continuing a 219-quarter streak. Multiple investor conferences and communications have highlighted the dual VITAS hospice and Roto-Rooter businesses, similar in format to the new Oppenheimer conference appearance.
Key Terms
webcast technical
forward-looking statements regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
CINCINNATI, March 12, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on Thursday, March 19, 2026, at approximately 9:20 a.m. (ET).
The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
| CONTACT: | Michael D. Witzeman |
| (513) 762-6714 |